Understanding how E. coli behaves in the human gut
Official title: Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
Run by Assistance Publique - Hôpitaux de Paris · NCT05153824 · Data updated 2026-11-12
This study is trying to see how E. coli bacteria behave and change in the guts of healthy people to better understand its role in health and disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | March 2, 2021 |
| Main results expected | March 2, 2024 |
| Study ends | September 2, 2027 |
| Registry record updated | April 10, 2023 |
| Trial ID | NCT05153824 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 18 to 65 with normal gastrointestinal function.
✕Probably not a fit
Patients with chronic gastrointestinal illnesses or known immunosuppression are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the ecological and evolutionary dynamics of Escherichia coli within the digestive system of healthy individuals. It aims to quantify the changes in E. coli strains in the gut microbiota, focusing on how these changes are influenced by both host and bacterial characteristics. By studying a large population of healthy volunteers, the research seeks to shed light on the colonization dynamics of E. coli, which is crucial for understanding its role in antibiotic resistance and virulence. The study will also explore the intra-host evolution of E. coli over time.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing E. coli infections and antibiotic resistance.
How similar studies have gone: While studies on gut microbiota exist, this specific focus on E. coli dynamics in healthy individuals is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * healthy volunteer of both sexes between the ages of 18 and 65 years old included * subject considered healthy after a thorough general examination (interrogation, physical examination) * subject with normal transit with usually one molded saddle per day * BMI between 18.5 and 35 kg / m² included Exclusion Criteria: * Subject living in an institution * Known immunosuppression (HIV, concomitant immunosuppressive therapy, chemotherapy, long-term corticosteroids regardless of the dose\> 2 weeks in the last 6 months) * Chronic gastrointestinal illness (Chronic Hemorrhagic Recto-colitis, Crohn's Disease) * Any digestive resection except appendectomy and resection of polyps * Subject with a history (s) of bacteremia * Subject protected by law under guardianship or curator-ship * Pregnant or lactating woman * Subject deprived of liberty under judicial duress * Lack of affiliation to a social security scheme * Patient on State Medical Aid * Absence of signed consent before entering the study
Where it's running
-
Bichat Claude Bernard Hospital
Paris, France Recruiting -
Bichat Hospital, Clinical Investigation Center
Paris, France Recruiting
Study contacts
- Study coordinator: Xavier M DUVAL, MD, PhD
- Email: xavier.duval@aphp.fr
- Phone: +33 (0)1 40 25 71 48
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using phage therapy to treat bladder infections in spinal cord injury patients
This study is testing if a new treatment using viruses to target bacteria can help people with spinal cord injuries who have bladder infections caused by E. coli.
-
High volume fluid treatment for children with E. coli infection
This study is testing if giving children with a serious E. coli infection more fluids through an IV can help prevent kidney problems and other complications.
-
Using fecal microbiota transplantation to treat severe intestinal infections
This study is testing whether a new way of using fecal transplants can help people with severe intestinal infections, like C. difficile, feel better and recover.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.